News
More than one in five UK adults tried to access weight-loss medications in the past year alone, according to a survey by the ...
Eli Lilly will seek regulatory approval for its next-generation weight-loss pill by year-end, based on data that suggests it ...
Danone has launched a drinkable yogurt product under its Oikos brand in the US which looks to target users of Ozempic and ...
17h
Everyday Health on MSNGLP-1 Pill Helped People With Obesity Lose Almost 30 Pounds in New TrialPeople who took the daily pill orforglipron lost 12 percent of body weight on average after 72 weeks, according to clinical ...
The partnership means that Apple's fitness and wellness service will be made available to all members who enrol onto ...
Drugmaker Eli Lilly says after successful results in a phase 3 clinical trial, it expects to submit a GLP-1 weight loss pill ...
Cleaning his plate — and sometimes a second plate — was a household requirement during Charles’s childhood. “It served me ...
A recent survey revealed that over 1 in 10 Americans have used a GLP-1 drug for weight loss.Survey results indicated that up ...
A new study in mice has found that muscle loss associated with weight loss from GLP-1 medications like Ozempic may not be as ...
Drugs such as Ozempic, Wegovy and Mounjaro (known as semaglutide and tirzepatide) have changed the way clinicians manage ...
Danone is launching Oikos Fusion, a dairy-based drink targeting U.S. consumers using weight loss medications like Wegovy.
Two studies were conducted to verify concerns about diabetic retinopathy that were raised during initial trials of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results